WiseGuyReports.com adds “Global Cancer Antigen Market Size, Status and Forecast 2019-2025” reports to its database.
— Cancer Antigen Market:
The global cancer antigen market is anticipated to grow considerably in the next five years, according to a recently published report. Cancer antigens are specific proteins secreted into the human bloodstream, which are measurable in both cancerous and non-cancerous conditions. Cancer antigens are the tumour markers produced by cancerous cells and other cells of the body, which provide important information about cancer.
It is possible to detect cancer by testing blood samples to gauge the level of cancer antigens present in the bloodstream. Cancer antigens can be measured during treatment, before treatment, and after treatment. A high level of cancer antigens indicates that the treatment is ineffective, while a low cancer antigen level means that the cancer is responding to the treatment. Cancer antigens are considered to be markers for various types of cancers such as peritoneal cancer, fallopian tube cancer, ovarian cancer, endometrial cancer, breast cancer, and pancreatic cancer, and this is likely to drive the market growth. According to WHO (World Health Organisation), cancer is one of the leading causes of death worldwide, responsible for approximately 9.6 million deaths in 2018, which is another factor likely to drive the market. However, because of the limitation of cancer antigens being useful for the detection of only a few types of cancer, market growth might be hindered.
The objectives of this report are the analysis of the cancer antigen market status, forecast of future prospects, and an examination of growth opportunities, key regional markets, and the key market players. It profiles the market players in a strategic manner, and provides comprehensive analyses of their development plans and business strategies. It is designed to describe, define, and forecast the global cancer antigen market on the basis of product types, applications, and key regions.
The global cancer antigen market is segmented basis Type and Application.
Based on types, the global cancer antigen market is divided into Cancer antigen 125, Cancer antigen 15-3, Cancer antigen 27-29, Cancer antigen 19-9, and others.
From the application perspective, it is segmented into hospitals, diagnostic centres, and ambulatory surgical centres, and other applications. Cancer antigen 125 (CA125) is used to detect ovarian cancer, while CA 15-3 and CA 27-29 are used as markers to detect breast cancer.
At a geographical level, the global cancer antigen market is comprised of North America, Europe, and Asia-Pacific. North America is likely to hold the largest market share because of the high level of patient awareness, and the existence of a large number of market players. The fastest market growth is likely to be recorded in the Asia-Pacific region, due to the rising prevalence of various types of cancer in this region.
Checking levels of Cancer antigen 125 in the blood is useful for assessing the chances of ovarian cancer, and might even help with the detection of other kinds of cancer among patients in primary care, according to a presentation at the 2019 National Cancer Research Institute Cancer Conference. Even though the CA125 test is already popular globally, this is the first large scale research to test its performance in general practice.
For further information on this report, visit - https://www.wiseguyreports.com/reports/4584643-global-cancer-antigen-market-size-status-and-forecast-2019-2025
Name: Norah Trent
Email: Send Email
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528/524, Amanora Chambers, Magarpatta Road, Hadapsar Pune, Maharashtra 411028
Phone: +1 (339) 368 6938 (US) +44 208 133 9349 (UK)
Release ID: 88937276